Cutter Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-798,137
Closed -$6.07M 26
2024
Q3
$6.07M Sell
798,137
-1,177,161
-60% -$8.95M 1.79% 24
2024
Q2
$12.2M Sell
1,975,298
-130,161
-6% -$804K 3.68% 14
2024
Q1
$10.7M Buy
2,105,459
+583,647
+38% +$2.96M 4.09% 11
2023
Q4
$9.12M Buy
+1,521,812
New +$9.12M 4.36% 11